Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
BUSINESS
Sanofi Delays Japan Launch of Efluelda by One Year, Defers NIP Rollout
Sanofi has postponed the Japanese launch of its high-dose influenza vaccine Efluelda by one year to fall 2027 due to manufacturing delays, forcing the product’s planned introduction under the national immunization program (NIP) for the 2026/27 flu season to be…
To read the full story
Related Article
- Sanofi Japan Highlights Beyfortus Track Record with NIP Inclusion in Sight
November 11, 2026
- Japan Expects Flu Vaccine Supply of 51.9 Million Doses for 2026-27
August 27, 2026
- MHLW Panel Voices Disappointment over Efluelda Launch Delay
July 24, 2026
- Japan to Add High-Dose Flu Vaccine to NIP for Adults Aged 75 and Over
November 21, 2025
BUSINESS
- Nipro Eyes 50-60 Stemirac Treatment Sites across Japan after Full Nod
November 20, 2026
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- Japan Drug Makers’ Sales Seen Dipping in FY2026 on Co-Marketing Exits
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026





